GPX3 has been identified as a tumor suppressor in multiple cancers, where epigenetic regulation of its mRNA expression through hypermethylation of CpG islands in the promoter region specifically reduces transcriptional efficiency in many mammalian cancers [40,41]. Here, GPX3 is linked to cancer.